Net Loss of Sun Pharma Advanced Research Company reported to Rs 75.85 crore in the quarter ended September 2025 as against net loss of Rs 107.33 crore during the previous quarter ended September 2024. Sales declined 38.88% to Rs 7.86 crore in the quarter ended September 2025 as against Rs 12.86 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales7.8612.86 -39 OPM %-836.13-800.23 - PBDT-73.23-104.01 30 PBT-75.79-107.17 29 NP-75.85-107.33 29 Powered by Capital Market - Live News

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live News

Net Loss of Sun Pharma Advanced Research Company reported to Rs 51.87 crore in the quarter ended June 2025 as against net loss of Rs 95.90 crore during the previous quarter ended June 2024. Sales declined 42.65% to Rs 9.64 crore in the quarter ended June 2025 as against Rs 16.81 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales9.6416.81 -43 OPM %-540.25-555.38 - PBDT-49.13-92.36 47 PBT-51.81-95.50 46 NP-51.87-95.90 46 Powered by Capital Market - Live News

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on 4 August 2025.Powered by Capital Market - Live News

Sun Pharma Advanced Research Company announced that the 20th Annual General Meeting(AGM) of the company will be held on 12 August 2025.Powered by Capital Market - Live News